- Home
- TECX vs MOV Comparison
TECX vs MOV Comparison
Compare TECX & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- MOV
- Stock Information
- Founded
- TECX 2019
- MOV 1961
- Country
- TECX United States
- MOV United States
- Employees
- TECX N/A
- MOV N/A
- Industry
- TECX
- MOV Consumer Specialties
- Sector
- TECX
- MOV Consumer Discretionary
- Exchange
- TECX Nasdaq
- MOV Nasdaq
- Market Cap
- TECX 334.4M
- MOV 379.1M
- IPO Year
- TECX 2018
- MOV 1993
- Fundamental
- Price
- TECX $21.09
- MOV $16.18
- Analyst Decision
- TECX Buy
- MOV Strong Buy
- Analyst Count
- TECX 6
- MOV 1
- Target Price
- TECX $78.67
- MOV $31.50
- AVG Volume (30 Days)
- TECX 243.5K
- MOV 185.2K
- Earning Date
- TECX 08-13-2025
- MOV 05-29-2025
- Dividend Yield
- TECX N/A
- MOV 8.64%
- EPS Growth
- TECX N/A
- MOV N/A
- EPS
- TECX N/A
- MOV 0.78
- Revenue
- TECX N/A
- MOV $650,768,000.00
- Revenue This Year
- TECX N/A
- MOV $0.71
- Revenue Next Year
- TECX N/A
- MOV N/A
- P/E Ratio
- TECX N/A
- MOV $20.37
- Revenue Growth
- TECX N/A
- MOV N/A
- 52 Week Low
- TECX $13.70
- MOV $12.85
- 52 Week High
- TECX $61.07
- MOV $26.59
- Technical
- Relative Strength Index (RSI)
- TECX 50.45
- MOV 57.14
- Support Level
- TECX $19.13
- MOV $15.20
- Resistance Level
- TECX $20.75
- MOV $16.46
- Average True Range (ATR)
- TECX 1.33
- MOV 0.43
- MACD
- TECX -0.10
- MOV 0.07
- Stochastic Oscillator
- TECX 56.73
- MOV 83.71
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.